Shuyin Ze

机构：East China Normal University

发表论文 8 篇 · 总被引 155 次 · h-index 6

代表论文

• The lactate receptor HCAR1 drives the recruitment of immunosuppressive PMN-MDSCs in colorectal cancer (2025 · Nature Immunology · 被引 67)
• Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A 2A Receptor Antagonists for Cancer Immunotherapy (2023 · Journal of Medicinal Chemistry · 被引 25)
• Natural product piperine alleviates experimental allergic encephalomyelitis in mice by targeting dihydroorotate dehydrogenase (2020 · Biochemical Pharmacology · 被引 23)
• Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8 H )-one Derivatives as Novel Potent Adenosine A 2A Receptor Antagonists for Cancer Immunotherapy (2022 · Journal of Medicinal Chemistry · 被引 16)
• Discovery of Orally Available Retinoic Acid Receptor-Related Orphan Receptor γ-t/Dihydroorotate Dehydrogenase Dual Inhibitors for the Treatment of Refractory Inflammatory Bowel Disease (2021 · Journal of Medicinal Chemistry · 被引 13)
• Subtle Structural Changes across the Boundary between A 2A R/A 2B R Dual Antagonism and A 2B R Antagonism: A Novel Class of 2-Aminopyrimidine-Based Derivatives (2024 · Journal of Medicinal Chemistry · 被引 10)